M M Almurdhi1, N D Reeves2, F L Bowling1, A J M Boulton1, M Jeziorska1, R A Malik1,3. 1. Centre for Endocrinology and Diabetes, Institute of Human Development, University of Manchester and Central Manchester NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK. 2. School of Healthcare Science, Faculty of Science and Engineering, Manchester Metropolitan University, Manchester, UK. 3. Weill-Cornell Medicine-Qatar, Doha, Qatar.
Abstract
AIM: To quantify muscle strength and size in subjects with impaired glucose tolerance (IGT) in relation to intramuscular non-contractile tissue, the severity of neuropathy and vitamin D level. METHODS: A total of 20 subjects with impaired glucose tolerance and 20 control subjects underwent assessment of strength and size of knee extensor, flexor and ankle plantar and dorsi-flexor muscles, as well as quantification of intramuscular non-contractile tissue and detailed assessment of neuropathy and serum 25-hydroxy vitamin D levels. RESULTS: In subjects with impaired glucose tolerance, proximal knee extensor strength (P = 0.17) and volume (P = 0.77), and knee flexor volume (P = 0.97) did not differ from those in control subjects. Ankle plantar flexor strength was significantly lower (P = 0.04) in the subjects with impaired glucose tolerance, with no difference in ankle plantar flexor (P = 0.62) or dorsiflexor volume (P = 0.06) between groups. Intramuscular non-contractile tissue level was significantly higher in the ankle plantar flexors and dorsiflexors (P = 0.03) of subjects with impaired glucose tolerance compared with control subjects, and it correlated with the severity of neuropathy. Ankle plantar flexor muscle strength correlated significantly with corneal nerve fibre density (r = 0.53; P = 0.01), a sensitive measure of small fibre neuropathy, and was significantly lower in subjects with vitamin D deficiency (P = 0.02). CONCLUSIONS: People with impaired glucose tolerance have a significant reduction in distal but not proximal leg muscle strength, which is not associated with muscle atrophy, but with increased distal intramuscular non-contractile tissue, small fibre neuropathy and vitamin D deficiency.
AIM: To quantify muscle strength and size in subjects with impaired glucose tolerance (IGT) in relation to intramuscular non-contractile tissue, the severity of neuropathy and vitamin D level. METHODS: A total of 20 subjects with impaired glucose tolerance and 20 control subjects underwent assessment of strength and size of knee extensor, flexor and ankle plantar and dorsi-flexor muscles, as well as quantification of intramuscular non-contractile tissue and detailed assessment of neuropathy and serum 25-hydroxy vitamin D levels. RESULTS: In subjects with impaired glucose tolerance, proximal knee extensor strength (P = 0.17) and volume (P = 0.77), and knee flexor volume (P = 0.97) did not differ from those in control subjects. Ankle plantar flexor strength was significantly lower (P = 0.04) in the subjects with impaired glucose tolerance, with no difference in ankle plantar flexor (P = 0.62) or dorsiflexor volume (P = 0.06) between groups. Intramuscular non-contractile tissue level was significantly higher in the ankle plantar flexors and dorsiflexors (P = 0.03) of subjects with impaired glucose tolerance compared with control subjects, and it correlated with the severity of neuropathy. Ankle plantar flexor muscle strength correlated significantly with corneal nerve fibre density (r = 0.53; P = 0.01), a sensitive measure of small fibre neuropathy, and was significantly lower in subjects with vitamin D deficiency (P = 0.02). CONCLUSIONS:People with impaired glucose tolerance have a significant reduction in distal but not proximal leg muscle strength, which is not associated with muscle atrophy, but with increased distal intramuscular non-contractile tissue, small fibre neuropathy and vitamin D deficiency.
Authors: G Lauria; S T Hsieh; O Johansson; W R Kennedy; J M Leger; S I Mellgren; M Nolano; I S J Merkies; M Polydefkis; A G Smith; C Sommer; J Valls-Solé Journal: Eur J Neurol Date: 2010-07 Impact factor: 6.089
Authors: Jolita Ciapaite; Sjoerd A van den Berg; Sander M Houten; Klaas Nicolay; Ko Willems van Dijk; Jeroen A Jeneson Journal: J Nutr Biochem Date: 2014-10-25 Impact factor: 6.048
Authors: Omar Asghar; Ioannis N Petropoulos; Uazman Alam; Wendy Jones; Maria Jeziorska; Andrew Marshall; Georgios Ponirakis; Hassan Fadavi; Andrew J M Boulton; Mitra Tavakoli; Rayaz A Malik Journal: Diabetes Care Date: 2014-06-26 Impact factor: 19.112
Authors: John R Singleton; Robin L Marcus; Justin E Jackson; Margaret K Lessard; Timothy E Graham; Albert G Smith Journal: Ann Clin Transl Neurol Date: 2014-10-12 Impact factor: 4.511
Authors: M R Lopes; Paula A B Ribeiro; Priscila Ledur; Gabriela C Souza; Nadine Clausell; Beatriz D Schaan Journal: J Diabetes Res Date: 2014-08-25 Impact factor: 4.011
Authors: Alon Abraham; Majed Alabdali; Abdulla Alsulaiman; Ari Breiner; Carolina Barnett; Hans D Katzberg; Leif E Lovblom; Bruce A Perkins; Vera Bril Journal: PLoS One Date: 2016-11-08 Impact factor: 3.240
Authors: Christine M Latham; Camille R Brightwell; Alexander R Keeble; Brooke D Munson; Nicholas T Thomas; Alyaa M Zagzoog; Christopher S Fry; Jean L Fry Journal: Front Physiol Date: 2021-04-14 Impact factor: 4.566
Authors: Francesco Palmese; Rossella Del Toro; Giulia Di Marzio; Pierluigi Cataleta; Maria Giulia Sama; Marco Domenicali Journal: Nutrients Date: 2021-04-20 Impact factor: 5.717